Regeneron Pharmaceuticals, Inc.

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

18,485

Value ($000)

14,268

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	14,268	0.1%	18,485	12/31/2025
2025 Q3	11/13/2025	8,578	0.0%	15,256	9/30/2025
2025 Q2	8/14/2025	8,835	0.1%	16,829	6/30/2025
2025 Q1	5/14/2025	13,109	0.1%	20,669	3/31/2025
2024 Q4	2/18/2025	14,789	0.1%	20,761	12/31/2024
2024 Q3	11/14/2024	19,010	0.1%	18,083	9/30/2024
2024 Q2	8/14/2024	21,729	0.1%	20,674	6/30/2024
2024 Q1	5/15/2024	12,353	0.1%	12,834	3/31/2024
2023 Q4	2/14/2024	10,792	0.1%	12,288	12/31/2023
2023 Q3	11/14/2023	8,073	0.1%	9,810	9/30/2023
2023 Q2	8/11/2023	6,966	0.1%	9,695	6/30/2023
2023 Q1	5/12/2023	7,851	0.1%	9,555	3/31/2023
2022 Q4	2/13/2023	6,860	0.1%	9,508	12/31/2022
2022 Q3	11/10/2022	7,363	0.1%	10,688	9/30/2022
2022 Q2	8/12/2022	7,317	0.1%	12,378	6/30/2022
2022 Q1	5/12/2022	11,399	0.1%	16,321	3/31/2022
2021 Q4	2/11/2022	11,663	0.1%	18,468	12/31/2021
2021 Q3	11/12/2021	11,719	0.1%	19,365	9/30/2021
2021 Q2	9/29/2021	10,885	0.1%	19,489	6/30/2021
2021 Q1	4/30/2021	8,142	0.1%	17,209	3/31/2021
2020 Q4	2/2/2021	8,547	0.1%	17,692	12/31/2020
2020 Q3	11/10/2020	9,793	0.1%	17,494	9/30/2020
2020 Q2	8/12/2020	10,080	0.1%	16,163	6/30/2020
2020 Q1	5/13/2020	4,324	0.1%	8,856	3/31/2020
2019 Q4	2/12/2020	7,172	0.1%	19,101	12/31/2019
2014 Q2	7/7/2014	8,822	0.1%	31,231	6/30/2014
2014 Q1	4/15/2014	9,702	0.1%	32,310	3/31/2014
2013 Q4	1/15/2014	11,988	0.1%	43,554	12/31/2013